Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-09-17
2011-10-18
Dentz, Bernard (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S438000, C514S604000, C514S605000, C549S075000, C546S334000, C564S091000, C564S092000, C564S099000
Reexamination Certificate
active
08039493
ABSTRACT:
The invention is concerned with novel biaryl sulfonamide derivatives of formula (I)wherein R1to R3and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to LXR alpha and LXR beta and can be used as medicaments.
REFERENCES:
patent: WO 00/54759 (2000-09-01), None
patent: WO 03/099769 (2003-12-01), None
patent: WO 03/099775 (2003-12-01), None
Anderson et al,Molecular Pharmacology, 66:6 (2004) 1440-1452 XP009115071.
Panday et al,Bioorganic&Medicinal Chemistry Letters, 16:19 5231-5237 (2006).
Lund et al., Arterioscler. Thomb. Vasc. Biol., 23, pp. 1169-1177 (2003).
Mitro et al., Nature, 445, pp. 219-223 (2007).
Joseph et al., Curr. Opin. Pharmacol, 3, pp. 192-197 (2003).
Cao et al., J. Biol. Chem., 278, pp. 1131-1136 (2003).
Dehmlow Henrietta
Obst Sander Ulrike
Schulz-Gasch Tanja
Wright Matthew
Dentz Bernard
Hoffmann-La Roche Inc.
Johnston George W.
Remy Brian C.
Tramaloni Dennis P.
LandOfFree
Biaryl sulfonamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biaryl sulfonamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biaryl sulfonamide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4291478